The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.
J Psychopharmacol – July 19, 2010
Source: PubMed Central
Summary
Many individuals with severe post-traumatic stress disorder (PTSD) find little relief from conventional methods. A pilot investigation explored if MDMA-assisted psychotherapy could offer a breakthrough. Participants with chronic, treatment-resistant PTSD received therapy, either with or without MDMA. The results were remarkably positive, showing significant reductions in PTSD symptoms and a favorable safety profile. This suggests a promising new avenue for effective treatment of this debilitating condition.
Abstract
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.